Followers | 36 |
Posts | 2,689 |
Boards Moderated | 0 |
Alias Born | 06/09/2011 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good points and I believe and just a guess a UCLA radiologist who has contributed to and provides support of the Liau, Prins research at UCLA.
I am not sure so maybe someone else with this experience would know and post that answer.
GLTA Longs!
Dcvax immunotherapy and pseudoprogression radiologic review and assesments
steve wilson
steve wilson
Published November 9, 2017
UCLA presentation very interesting and worth watching!
Absolutely Sojourner55!!
Amazing trading up$.45 pre-market on over 770k shares! Someone knows something this volume is so strong!
GLTA!
NICE update now includes DCVax documents as of August 16, 2017 and I expect if DCVax-L trial data is statistically significant and FDA grants AA I see NICE facilitating this application to bring this treatment to brain cancer patients in the UK well in advance of the April 2019 expected publication date. This is JMO.
https://www.nice.org.uk/guidance/indevelopment/gid-ta10143/documents
Volume has really picked up the pace in last 30 minutes!
Smokey look what occurred with CLSN yesterday and I am holding it, announced excellent data from Phase Ib trial in Stage 3/4 Ovarian cancer and stock with a low float traded over 72M shares yesterday and ran from $1.95 open to $6.84 AH. It will run even more today and coming days now.
JMO-I can see this happening with NWBO on strong Phase III data announcement as we all know with 98 patients still alive (30%) in a trial of 331 and over 24 months since last patient enrolled is pretty incredible.
You have called this PPS movement so well all day today! Thanks for sharing!
Top 10 Significant Facts on Brain Tumor Awareness
My Comment: just an FYI as I came across this as this person obviously has had DCVax at some time in his treatment of his three brain tumor surgeries.
https://keyabheer.tumblr.com/post/165851219122/top-10-significant-facts-on-brain-tumor-awareness
Great find longfellow95! I get the feeling something big is in the works after seeing this. NIH $11.4M grant with UCLA Brain Cancer Program
Northwest Biotherapeutics, Inc (OTCMKTS:NWBO) Shares Find a Foothold on Update
By Jermaine Farmer - September 8, 2017
https://oracledispatch.com/2017/09/08/northwest-biotherapeutics-inc-otcmktsnwbo-shares-find-foothold-update/
I like the very end of the interview! Great find Senti!
What a great find forumreader35!
FYI-Found this interesting as Fraunhofer updated the following links by clicking on the tabs and document links you will notice details on size of total clean rooms, projects including Prima Biomed project now completed. If DCVax was a scam or failure why would Fraunhofer continue to keep DCVax on this important part of the Fraunhofer Institute?
https://www.izi.fraunhofer.de/en/departments/leipzig-location/gmp-cell-and-gene-therapy.html#tabpanel-1
Global Glioblastoma Multiforme Market is Expected to Reach USD 898.9 Mn by 2022: Credence Research
Chris Paul August 17, 2017, 9 mins ago News
http://www.pdfdevices.com/global-glioblastoma-multiforme-market-is-expected-to-reach-usd-898-9-mn-by-2022-credence-research-2/
Great find and thanks for sharing wavelengthy as this was published on July 18, 2017 and Keyoumars Askan is the European Chief Investigator for the DCvax trial. This is very encouraging!
Targeting Cancer with 3 Key Spotlight Sessions on the Latest Therapy Breakthroughs
EIN Presswire
August 16, 2017
Categories Press Releases
http://www.todayinthenews.com/2017/08/16/targeting-cancer-with-3-key-spotlight-sessions-on-the-latest-therapy-breakthroughs/
Thanks alphapupphy for your work on this....very interesting and again thank you for taking your time to put this together.
Well stated and great post beach!
Great post and well said da_woof2!
Because it was relevant to GBM and the article did reference the DCVax Phase III trial near the end of the story.
Meet the Fort Lee woman who survived glioblastoma ( DCVax mentioned towards end of article)
Lindy Washburn, Staff Writer, @LindyWa Published 12:48 p.m. ET July 20, 2017 | Updated 12:55 p.m. ET July 20, 2017
Nearly a decade after learning she had only three months to live, Sandy Hillburn grabbed a taxi last Sunday to La Guardia Airport for one of her regular "business trips" to North Carolina.
The Fort Lee resident signed in the next day at Duke University's Cancer Center -- her 111th visit as a participant in a clinical trial about the most lethal form of brain cancer, glioblastoma. Hillburn is now the study's longest, and only, survivor.
http://www.northjersey.com/story/news/health/2017/07/20/surviving-glioblastoma/495768001/
Flip, looks like hiring by Cognate is a pretty compelling sign as it is still going on and add in all the clean room equipment. This is just my perspective but looking very obvious to me but just my opinion.
Thanks for posting this update!
Happy 4th to all patients, families, researchers and all supporting staff in this fight against this terrible disease!
I agree beach 100%!
Very nice find....thanks for sharing. My highlight in bold below from article.
NWBio Closes 3-Year Convertible Debt Exchange and Financing, and Completes Payoff of Last $5 Million of 2014 Bonds
Debt Convertible at $0.25, $.50 and $1.00; Secured By UK Property
http://www.prnewswire.com/news-releases/nwbio-closes-3-year-convertible-debt-exchange-and-financing-and-completes-payoff-of-last-5-million-of-2014-bonds-300478424.html
Sharpie, I totally agree with you and she went to UCLA and Dr Liau who is considered one of the premier neurosurgeon's in the world. She has been through so much over the years your heart aches for her to be cured. She is in my prayers as you read her blogs she is incredible woman and inspiration to many.
Jessica did not receive DCvax at UCLA and Dr. Liau did her most recent surgery a few months ago but I believe Jessica went to Germany for the Newcastle Dendritic Cell vaccine and went to New York to another doctor who administered the vaccine so she did not have to travel back and forth to Germany.
I wonder if she had her tumor tissue saved for the vaccine going forward?
Totally agree Flip!
Great point Flipper! Thanks for you continuing to share your viewpoints on this.
Highwayman....Yes this has been a long strange trip! We are coming to the finish line I believe and hope management has set this up well to get us into billion dollar market cap with some substantial news!
Eagle....yes just a vibe because of countdown on their web site just smells like potential to drop a huge announcement at close of market.
It will be interesting watching last 30 minutes until close.
GLTA patients, care givers, longs!
It might be a stretch but does anyone feel like NWBO does another PR at close with a major announcement like Direct upfront payment/royalties or L approval?
PR Out
Dr. Bosch's presentation will include updates on the Company's Phase III trial of DCVax-L for newly diagnosed Glioblastoma multiforme (GBM) brain cancer, as well as the Information Arm related to the GBM trial, and the Company's Phase I/II Trial of DCVax-Direct for inoperable solid tumors.
Dr. Bosch's presentation will be webcast live at:
https://www.nwbio.com/dcvax-novel-personalized-immune-therapies-solid-tumors/ It will also be available to review after the presentation on the Company's website www.nwbio.com under the heading "Most Recent Presentations." This presentation is not an official presentation of the 2017 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO or the Conquer Cancer
http://www.prnewswire.com/news-releases/dr-marnix-bosch-to-present-updates-about-dcvax-clinical-programs-today-300468529.html
Senti......great points made here and I agree with your viewpoint on this!
This may have been posted already Cancer Vaccines in UK. Northwest is listed sponsor and LP listed as a speaker as well.
CANCER VACCINES
27TH SEPTEMBER TO 28TH SEPTEMBER 2017,
LONDON, UNITED KINGDOM
GROWING YEAR ON YEAR, CANCER VACCINES 2017 RETURNS TO LONDON TO DISCUSS KEY DEVELOPMENTS IN THE IMMUNO ONCOLOGY SPHERE. THIS IS A MUST ATTEND EVENT FOR INDUSTRY LEADERS AND ONCOLOGY EXPERTS!
https://www.smi-online.co.uk/pharmaceuticals/uk/cancer-vaccines#tab_sponsors
gabbie1....thanks for sharing this real life experience on DCVax and your friend's niece with an inoperable brain tumor in the UK. What a great story of her inoperable tumor vanished after her 3rd injection of the vaccine. Great story for her and her family!
The relentless short attacks on NWBO over the past couple of years has really put a strain on the company to continue funding the trials in both GBM as well as Direct. The DCVax marathon is now on the last mile to the finish line! IMHO, we see DCVax gaining approval in US/UK/Germany and Canada in the next few months.
No question momentum2play on shorts and their strategy. I just believe as iwasdiver stated something significant going on with Cognate $28 Line, Cognate purchase of (16) biologic manufacturing machines, Nice Appraisal ( Jan-Feb 2017) non dilutive raises and their Feb 6, 2017 PR leads me to believe we hear that regulators stop this trial (before June 2017) before OS events occur due to statistical efficacy, This is just my opinion and I may be wrong but we will find out pretty soon!!
Thanks Dan! Agree with you 100% on this post!